Skip to content

Study · Not a test of the peptide alone · 2013

1 result

[TREATMENT OF CHEMICAL STOMATITIS IN PEOPLE OF ADVANCED AND SENILE AGE].

Filippova EV

Advances in gerontology = Uspekhi gerontologii1 Jan 2013

PMID28976153 (opens in a new tab)PepBankPUB-28976153

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Vesugen (KED) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Vesugen (KED).

  1. 01HumanNot a test of Vesugen (KED) aloneObservational studyEfficacy outcome

    In 22 elderly patients with chemical stomatitis and medication sialadenopathy, adding Vezugen and the dietary supplement Algiklam to the conventional regimen was reported to enhance treatment effectiveness.

    In plain wordsIn elderly patients with chemical stomatitis, adding Vezugen and Algiklam to usual treatment was reported to improve treatment effectiveness.

    Outcome
    IncreaseTreatment effectiveness
    Study

    n = 22

    Outcome group
    Wound healing · Gastrointestinal

    Source sentences

    Summary
    It is shown that the inclusion in the conventional regimen chemical stomatitis peptide bioregulator Vezugen and dietary supplement Algiklam enhances the effectiveness of the treatment gerontostomatologic patients suffering from chemical stomatitis combined with medication sialadenopathys.
    1 context sentence
    Summary · context
    The author presents the results of the surveillance of medical rehabilitation of 22 elderly patients suffering from chemical stomatitis combined with medication sialadenopathys that occurred after combined treatment of malignant tumors of oropharyngeal area.

    In this study, Vesugen (KED) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Vesugen (KED).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 17:05 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.